FDA-cleared profile

AV Cardiac CT

Philips Medical Systems Nederland B.V.

AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.
FDA source Exact FDA submission Checked 2026-09-06
Intended users
Qualified medical professionals, including radiologists, cardiologists and 3D technologists.
FDA source Exact FDA submission Checked 2026-09-06
Care setting and population
Patients suspected of or diagnosed with coronary artery disease undergoing gated conventional or spectral cardiac CT.
FDA source Exact FDA submission Checked 2026-09-06
Workflow role
Cardiac-CT visualization, coronary anatomy/function analysis, reporting and intervention-preparation support.
FDA source Exact FDA submission Checked 2026-09-06
Required input
Gated conventional or spectral cardiac CT data, including coronary CT angiography datasets.
FDA source Exact FDA submission Checked 2026-09-06
Output and human action
Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.
FDA source Exact FDA submission Checked 2026-09-06
Limitations
The device does not provide automatic diagnosis, clinical decisions or treatment recommendations. All outputs are reviewable and editable. Pre-PCI planning tools provide approximate vessel dimensions and C-arm angulation and are not for device selection or treatment decisions.
FDA source Exact FDA submission Checked 2026-09-06

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K260169
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA
FDA source Exact FDA submission Checked 2026-09-06
Anatomy
Heart/Cardiovascular
FDA source Exact FDA submission Checked 2026-09-06
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2026-03-05
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The current AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT as an integrated component and describes DICOM image exchange features.
Public source Product family Checked 2026-09-06

Later AVW V15.1.3 documentation; it does not establish the exact K260169 installed release or interfaces.

Deployment and data flow
Standalone software-only medical device.
FDA source Exact FDA submission Checked 2026-09-06

The summary does not establish a complete current hosting or network architecture.

Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-06

DICOM conformance and general connected-workflow language do not establish formal security controls for an installed configuration.

Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-06

Qualified-user intent does not establish a verified current training program.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-06

No verified monitoring service was found. Site acceptance should evaluate input quality, centerline/segmentation review, editability and reporting.

Current AVW DICOM family context

Philips' AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT within the AV Cardio Vascular Suite and describes receiving, storing, querying and exchanging DICOM images.

product family · checked 2026-09-06

This is current product-family documentation, not exact evidence for the K260169 configuration.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
The K260169 technical study used 80 CCTA cases and three observers' manual reference annotations. It measures algorithm agreement and labeling performance rather than clinical diagnostic or treatment outcomes.
FDA source Exact FDA submission Checked 2026-09-06
Reported sensitivity
91
FDA source Exact FDA submission Checked 2026-09-06

Major-vessel-label sensitivity in the technical CCTA performance evaluation, not diagnostic sensitivity for coronary artery disease.

Reported specificity
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-06

No disease-detection specificity was established by the reviewed technical-performance summary.

Coronary centerline overlap

0.93 overlap coefficient

Centerline overlap against manual reference in 80 CCTA cases with three-observer manual reference annotations.

Tested version: AV Cardiac CT configuration cleared in K260169

Major vessel-label sensitivity

91 percent

Sensitivity for major coronary-vessel labeling in 80 CCTA technical-performance cases.

Tested version: AV Cardiac CT configuration cleared in K260169

K260169 CCTA coronary-analysis technical performance evaluation

Manufacturer technical-performance evaluation compared with three-observer manual reference annotations · 80 CCTA cases from datasets spanning US, Europe and Asia

exact submission · Tested version: AV Cardiac CT configuration cleared in K260169 · n=80 · Sponsor or vendor study

K260169

Endpoints include coronary centerline, label and lumen-segmentation agreement. The study is not an autonomous diagnosis or clinical-outcome study.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-06

No public exact-version price or procurement record reviewed.

Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-09-06

No applicable CMS policy content reviewed; no coverage conclusion is made.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
22Fields reviewed
11Source classes checked
0Reviewed PubMed leads
0Reviewed trial leads
0Unreviewed FDA recall leads

Stored PubMed and ClinicalTrials candidate metadata snapshots were screened; both arrays were empty. No candidate evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, vendor documentation, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-06.

Alternatives

Related tools to compare

FDA-cleared K253786

syngo.CT Coronary Cockpit

Siemens Medical Solutions USA, Inc.

An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for...

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2026-06-25
FDA-cleared K243859

PRAEVAorta®2

Nurea

PRAEVAorta 2 assists clinical specialists, physicians, and other licensed practitioners with automatic vascular segmentation and maximum-diameter measurement on adult CT images;...

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-08-29